Trials / Terminated
TerminatedNCT00523328
BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)
An Open-Label Extension Study to Evaluate the Safety and Efficacy of BG9924 When Given in Combination With Methotrexate to Subjects With Rheumatoid Arthritis Who Previously Participated in Study 104RA203
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is to observe the long-term treatment of BG9924
Detailed description
Extension study for 104RA203 (NCT 00458861)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BG9924 | dosage administered as per Biogen-idec protocol |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2007-08-31
- Last updated
- 2016-01-21
Locations
4 sites across 4 countries: United States, Belgium, Canada, United Kingdom
Source: ClinicalTrials.gov record NCT00523328. Inclusion in this directory is not an endorsement.